Evaluation of Apoptosis and Neuronal Changes in the Compact Part of Substantia Nigra and Striatum Following the Use of Levodopa and Levodopa -Benserazide in Parkinson’s Rats
Authors:
Open Access
- 31 October 2018
- journal article
- Published by Brieflands in Annals of Military and Health Sciences Research
- Vol. In Press (In Press)
Abstract
Annals of Military and Health Sciences ResearchKeywords
This publication has 21 references indexed in Scilit:
- G-CSF for mobilizing transplanted bone marrow stem cells in rat model of Parkinson's disease2016
- Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson’s diseaseMolecular Neurodegeneration, 2015
- Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's diseaseNeurobiology of Aging, 2012
- Therapeutic approaches to mitochondrial dysfunction in Parkinson's diseaseParkinsonism & Related Disorders, 2009
- Oxidative and Inflammatory Pathways in Parkinson’s DiseaseNeurochemical Research, 2008
- l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiationNeurobiology of Disease, 2008
- A Model-Based Approach for Assessing Parkinsonian Gait and Effects of Levodopa and Deep Brain Stimulation2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 2006
- Post‐ versus presynaptic plasticity in L‐DOPA‐induced dyskinesiaJournal of Neurochemistry, 2006
- Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's diseaseNature Clinical Practice Neurology, 2006
- Does levodopa slow or hasten the rate of progression of Parkinson’s disease?Journal of Neurology, 2005